Pain management billing generates more questions per specialty than almost any other outpatient billing environment. The procedures are complex. The coding rules are approach-specific. The prior authorization requirements change by payer. And the revenue consequences of getting any of it wrong are disproportionately large because of the high per-claim value of interventional procedures.

These are the questions pain management physicians, practice managers, and billing staff ask most frequently answered directly and specifically, based on current 2026 AMA CPT guidelines, Medicare Physician Fee Schedule rates, and commercial payer standards.


Prior Authorization Questions

Q: Does Medicare require prior authorization for epidural steroid injections?

Medicare does not require prior authorization for most epidural steroid injections in the traditional Medicare program. However, services must meet Noridian’s (or the applicable MAC’s) Local Coverage Determination criteria — specific diagnosis codes, frequency limitations, and documentation standards. Medicare Advantage plans frequently do require prior authorization for ESI, and each MA plan has its own requirements. Always verify with the specific plan before scheduling.

Q: How many epidural steroid injections does Medicare cover per year?

Noridian’s LCD for epidural and intrathecal steroid injections generally limits coverage to three injections per spinal region per year. Exceeding this frequency without documented clinical exception results in denial. Some MACs and Medicare Advantage plans have different frequency standards. Track injection count per patient per spinal region as a standard billing workflow step.

Q: What documentation is required to get RFA prior authorization approved?

Most commercial payers and Medicare Advantage plans require documentation of two prior positive medial branch block responses before approving RFA. Each MBB procedure note must document: (1) the specific level and laterality treated, (2) the percentage of pain relief achieved (payer-specific threshold — 50% for most plans, 80% for some BCBS plans), and (3) the duration of relief. This documentation must be included in the authorization package — not just referenced. Incomplete MBB documentation is the most common reason RFA first-submission authorizations are denied.

Q: Do I need a separate prior authorization for SCS permanent implant after trial authorization?

Yes. SCS trial authorization and SCS permanent implant authorization are two separate documents required by virtually every commercial payer. The trial authorization covers electrode placement and trial assessment only. The permanent implant requires its own authorization, which must include documentation of trial success — typically ≥50% pain relief during the trial period. Initiate permanent implant authorization as soon as trial results are documented, not when the implant is scheduled.

Q: What happens if a prior authorization expires before the procedure is performed?

An expired authorization is treated as no authorization by the payer. If the procedure is performed after the authorization expiration date, the claim will be denied. Retro-authorization is available from some payers when the request is filed promptly after the expiration is discovered — typically within 30 days of the date of service. Prevent expiration lapses by tracking authorization end dates in a rolling calendar with renewal triggers set 2–3 weeks before expiration.

Q: Does Aetna require prior authorization for facet joint injections? (Pain Management Billing)

Yes. Aetna requires prior authorization for facet joint injections in most plan types. Aetna’s authorization requirements are published in their clinical policy bulletins. Required documentation typically includes diagnosis, imaging findings, conservative treatment history, and clinical examination findings consistent with facet-mediated pain. Verify current Aetna policy for the specific plan type — requirements vary between commercial, Medicare Advantage, and managed Medicaid plans.


CPT Coding Questions

Q: What is the difference between CPT 62323 and CPT 64483?

CPT 62323 is the lumbar/sacral interlaminar epidural steroid injection code with imaging guidance — used when the approach is from the posterior midline. CPT 64483 is the lumbar/sacral transforaminal epidural injection code, single level — used when the approach targets the nerve root foramen from a lateral oblique angle. These are different procedures with different reimbursement rates. The approach must be explicitly documented in the procedure note, and the CPT code billed must match the documented approach.

Q: When do I use CPT 64484 vs. 64483?

CPT 64483 is the primary code for a single-level lumbar/sacral transforaminal epidural injection. CPT 64484 is the add-on code for each additional level. If two levels are treated transforaminally (e.g., L4-5 and L5-S1), bill 64483 for the first level and 64484 for the second level. Document each level specifically in the procedure note.

Q: Can I bill CPT 77003 alongside transforaminal ESI codes?

Generally no. Imaging guidance is considered inherent to transforaminal epidural injection codes (64479–64484) by most payers. Separately billing 77003 alongside these codes frequently results in bundling — the guidance code is paid at zero. Verify your specific payer’s policy before billing 77003 with transforaminal codes. For interlaminar ESI codes (62320–62323), imaging guidance is separately billable when the “with imaging guidance” code variant is used (62321, 62323), though some payers still require documentation compliance.

Q: What CPT codes are used for radiofrequency ablation?

CPT 64633 — cervical or thoracic facet joint nerve, single level CPT 64634 — cervical or thoracic, each additional level (add-on) CPT 64635 — lumbar or sacral facet joint nerve, single level CPT 64636 — lumbar or sacral, each additional level (add-on)

Document the specific levels and laterality treated. Bill add-on codes for each additional level documented. RFA requires prior authorization from most payers.

Q: What CPT code is used for spinal cord stimulator trial?

CPT 63650 — percutaneous implantation of neurostimulator electrode array, epidural (trial) CPT 63655 — laminectomy for implantation of neurostimulator electrodes, plate/paddle (trial)

CPT 63650 is the standard percutaneous trial code. 63655 is used when a surgical (laminectomy) approach is used for paddle electrode placement. Document the approach and electrode placement level.

Q: What is the new HCPCS code for SCS permanent implants in 2026?

HCPCS code C1607 — implantable integrated neurostimulator device — was introduced in 2026 to identify integrated SCS devices. This replaces prior generic device coding for qualifying SCS permanent implants. Update your device master file to include C1607 for 2026 claims. Claims submitted with outdated device codes may be rejected by payers with updated edit logic.

Q: How do I bill trigger point injections when three muscles are treated?

CPT 20553 — injection, single or multiple trigger point(s), 3 or more muscles. Bill 20553 when three or more individual muscles are treated and each muscle is documented by name in the procedure note. CPT 20552 covers 1–2 muscles. The code must match the documented muscle count exactly. Trigger point injection claims are frequently audited — document the specific muscle names, the substance injected, and the clinical rationale.

Q: What CPT code is used for occipital nerve block?

CPT 64405 — injection, anesthetic agent, greater occipital nerve. If bilateral occipital nerve blocks are performed, apply Modifier 50 (bilateral) or bill with RT/LT modifiers depending on payer preference. Document the substance injected, concentration, volume, and the clinical indication.

Q: What is the difference between CPT 64490 and 64493?

CPT 64490 — paravertebral facet joint or nerve injection, cervical or thoracic, single level CPT 64493 — paravertebral facet joint or nerve injection, lumbar or sacral, single level

Both codes cover facet joint procedures (intra-articular injections or medial branch blocks). Code selection depends on spinal level — cervical/thoracic uses 64490; lumbar/sacral uses 64493. Add-on codes for additional levels: 64491 (cervical/thoracic second level), 64492 (third and additional), 64494 (lumbar/sacral second level), 64495 (third and additional).


Imaging Guidance Documentation Questions

Q: What documentation is required to bill CPT 77003 for fluoroscopic guidance?

Three elements must be present in the patient chart before CPT 77003 can be billed:

  1. The procedure note must document that fluoroscopic guidance was used
  2. A permanent image record must be created and retained in the patient’s chart
  3. A separate interpretation report must be documented by the provider

Missing any of these three elements makes the imaging guidance code unbillable — and billing it without all three creates post-payment audit exposure. Verify all three elements as a pre-submission checklist step on every imaging-guided procedure claim.

Q: What is the difference between CPT 77003 and CPT 76942?

CPT 77003 covers fluoroscopic guidance — using X-ray/fluoroscopy to guide needle placement. CPT 76942 covers ultrasound guidance — using real-time ultrasound imaging to guide needle placement. Bill the code that matches the imaging modality actually used. Both require the same three documentation elements: documentation of use, permanent image record, and interpretation report.

Q: Can I bill imaging guidance on every pain management procedure?

No. Imaging guidance is separately billable only when it is actually used, documented, and the documentation requirements are met. For some procedure codes (transforaminal ESI), guidance is inherent and should not be separately billed. For others (interlaminar ESI, joint injections), it is separately billable when documentation requirements are met. Billing imaging guidance codes on procedures where guidance wasn’t used is fraudulent billing.


Modifier Questions

Q: When do I need Modifier 50 for pain management procedures?

Modifier 50 identifies bilateral procedures performed at the same anatomical site on both sides. It is used when bilateral facet injections (same level, both sides), bilateral RFA, or bilateral nerve blocks are performed in the same session. Some payers prefer Modifier 50; others require separate claim lines with RT and LT modifiers. Know your payer’s specific bilateral billing preference — applying the wrong bilateral modifier approach produces denials or incorrect payment.

Q: When is Modifier 25 required on pain management claims?

Modifier 25 is required on the E/M code when a separately identifiable evaluation and management service is performed on the same date as a procedure. When a pain management physician evaluates a patient and performs an interventional procedure during the same visit, the E/M code must carry Modifier 25. Without it, the payer bundles the E/M into the procedure payment and the E/M is reimbursed at zero.

Q: What modifiers are used for multiple procedures on the same day?

When multiple procedures are billed on the same claim, Modifier 51 (multiple procedures) is applied to secondary and tertiary procedures to signal that multiple procedure reductions should be applied. Most payer systems apply this automatically, but some require manual application. The reduction percentage is payer-specific and should be verified against your contracted rate — payers sometimes apply reductions above the contracted percentage.

Q: Does Medicare require Modifier AT for pain management procedures?

Modifier AT (active treatment) was originally developed for chiropractic Medicare billing. It is not routinely required for interventional pain management procedures billed under pain management physician NPIs. However, some physical medicine and rehabilitation practitioners billing pain management procedures may encounter AT modifier requirements depending on how their services are coded and their enrolled specialty. Verify with your specific MAC if questions arise about AT applicability to your billing context.


E/M Coding Questions

Q: What E/M code should I use for a pain management follow-up visit?

The appropriate E/M code depends on the medical decision-making complexity of the specific visit or the total time spent. Under 2021 AMA guidelines:

  • 99213 — Low complexity: single stable chronic pain condition, minor medication check
  • 99214 — Moderate complexity: multiple pain conditions managed simultaneously, medication adjustment with monitoring, reviewing diagnostic results, new problem assessment
  • 99215 — High complexity: severe uncontrolled pain, high-risk medication management (opioids with PDMP review and monitoring protocol), hospitalization decision, treatment escalation

Most pain management follow-up visits involve management of multiple conditions with prescription drug management — supporting 99214. Visits involving opioid prescribing with documented PDMP review and monitoring protocols, or hospitalization decisions, support 99215.

Q: Can I bill an E/M on the same day as an interventional procedure?

Yes. When a separately identifiable evaluation and management service is performed on the same day as a procedure, both are separately billable. The E/M code must have Modifier 25 appended. The E/M must be documented as a service distinct from the pre-procedure evaluation that is inherent to the procedure itself. Document the clinical decision-making, medication management, or new problem evaluation that constitutes the separately identifiable E/M service.

Q: What is the Medicare rate for 99214 and 99215 in pain management for 2026?

Under the 2026 Medicare Physician Fee Schedule in a non-facility setting:

  • 99214 — approximately $148.90
  • 99215 — approximately $192.38

The $43 differential between these two codes, applied across hundreds of qualifying established patient visits per month, represents significant annual revenue in a pain management practice.


Payment and Reimbursement Questions

Q: What is the Medicare allowable for lumbar transforaminal ESI (CPT 64483)?

Medicare reimbursement for CPT 64483 (lumbar/sacral transforaminal epidural injection, single level) under the 2026 MPFS is approximately $185–$230 in the non-facility setting, depending on geographic locality adjustment. Rates vary by locality and setting. Verify the exact rate for your jurisdiction through CMS’s MPFS lookup tool or your MAC’s fee schedule.

Q: Why is my payer paying less than my contracted rate for multi-procedure sessions?

When multiple procedures are billed in the same session, payers apply multiple procedure reductions to secondary procedures. The contracted reduction percentage is specified in your participation agreement. When a payer applies a higher reduction percentage than what the contract specifies — for example, 60% when your contract says 50% — the difference is an underpayment. Without systematic ERA reconciliation against contracted rates at payment posting, these underpayments are written off as standard contractual adjustments. They are recoverable through a formal underpayment dispute process.

Q: Can I appeal an underpayment from a commercial payer?

Yes. When a payer pays below the contracted rate — through overapplied multiple procedure reductions, fee schedule discrepancies, or incorrect pricing — you have the right to dispute the payment under the participation agreement. File a formal underpayment dispute with the payer, citing the contract language specifying the correct rate, and calculate the variance across all affected claims. Most commercial payers have dispute windows of 12–18 months from the date of payment. File as soon as the underpayment is identified.

Q: Does BCBS require 80% pain relief for RFA authorization, or is 50% sufficient?

BCBS plans vary. Most Blue Cross Blue Shield plans require documentation of at least 80% pain relief from each diagnostic medial branch block for RFA authorization — stricter than Medicare’s 50% threshold. BCBS of Wyoming, BCBS of Colorado, and most Blue plans follow this 80% standard. Verify the specific threshold for each BCBS plan your practice is contracted with before submitting RFA authorizations. Submitting with documentation of only 50% relief to a payer requiring 80% will produce an automatic denial.

Q: How does multiple procedure reduction work for pain management claims?

When two or more procedures are billed in the same session, Medicare pays the highest-valued procedure at 100% of the allowable and each additional procedure at 50%. Commercial payers apply their contracted reduction percentage, which may be different from Medicare’s 50%. The billing system should apply Modifier 51 to secondary procedures. The key issue: verify that the payer’s applied reduction percentage matches what your contract specifies. Overapplied reductions are a common and systematic source of underpayment in pain management billing.


Denial Management Questions

Q: Why do pain management claims get denied for medical necessity?

Medical necessity denials in pain management occur when the clinical documentation doesn’t clearly establish that the procedure meets the payer’s coverage criteria. The most common documentation gaps:

  • Radicular symptoms not documented (ESI typically requires documented radiculopathy, not just axial pain)
  • Imaging not correlated with the treated level
  • Conservative treatment history insufficient or missing
  • Functional impairment not documented
  • Frequency limits exceeded without documented exception

The fix is documentation — not coding. Verify documentation meets payer-specific medical necessity criteria before the claim is submitted.

Q: What is the most common reason RFA claims are denied?

Insufficient or incomplete diagnostic medial branch block documentation. Payers deny RFA authorization and claims when the MBB documentation doesn’t clearly establish two prior positive responses with the required pain relief percentage and duration. The MBB procedure notes must be included in the authorization package — not just referenced by date.

Q: How do I appeal a pain management claim denied for lack of prior authorization?

When a claim is denied for lack of prior authorization, first assess whether retro-authorization is available. Most commercial payers allow retro-authorization requests within 30 days of the date of service when the denial resulted from an administrative oversight rather than a coverage exclusion. File the retro-authorization request with complete clinical documentation immediately after the denial is received. If retro-authorization is denied, evaluate whether a formal appeal with clinical justification is warranted under the payer’s appeals process.

Q: What is a peer-to-peer review and when should I request one?

A peer-to-peer review is a direct conversation between your treating physician and the payer’s medical director or clinical reviewer. It is the highest-overturn-rate appeal pathway for medical necessity denials on interventional pain procedures. When an RFA, SCS, or complex interventional procedure claim is denied for medical necessity after a standard appeal, requesting a peer-to-peer review allows the treating physician to directly explain the clinical rationale that the written documentation may not fully convey. Most payers allow peer-to-peer requests within 30 days of a medical necessity denial. Request it proactively for high-value interventional denials — don’t wait for written appeal results.

Q: What is timely filing and how does it affect pain management billing?

Timely filing is the payer’s deadline for receiving a claim after the date of service. Medicare’s timely filing limit is 12 months from the date of service. Commercial payers typically allow 90 days to 12 months, depending on the contract. Claims submitted after the timely filing deadline are denied and are not recoverable regardless of clinical appropriateness or coding accuracy. Track timely filing deadlines as part of the AR workflow and escalate approaching deadlines immediately.


Compliance Questions

Q: Is billing imaging guidance without a permanent image record considered fraudulent?

Yes. Billing CPT 77003 or CPT 76942 without the required documentation — permanent image record in the chart and separate interpretation report — constitutes billing for a service without the documentation to support it. When identified on post-payment audit, this produces recoupment demands. Systematic billing of imaging guidance without documentation requirements may trigger False Claims Act exposure. Always verify documentation requirements before billing imaging guidance codes.

Q: What happens if my pain management practice is audited by Medicare?

Medicare audits of pain management practices are conducted through Targeted Probe and Educate (TPE) reviews, Comprehensive Error Rate Testing (CERT), and Recovery Audit Contractor (RAC) reviews. When an audit finds billing inaccuracies, Medicare may request repayment of the overpaid amounts — calculated either on the specific audited claims or extrapolated across all claims in the audit period. The best audit protection is documentation that clearly supports every billed service before the claim is submitted. When an audit notice is received, respond promptly with organized documentation and consider engaging a billing compliance specialist.

Q: Can a pain management practice bill for services rendered by a CRNA?

Yes. CRNAs can perform certain pain management procedures under physician supervision. Billing depends on the setting, the nature of the service, and the supervision level. Under Medicare, CRNAs performing anesthesia services bill under their own NPI. CRNAs performing interventional procedures in a pain management office setting may bill under the physician’s NPI when incident-to rules are met. Verify the applicable supervision rules, billing requirements, and payer-specific policies for your practice’s specific situation.

Q: What is the OIG’s position on pain management billing?

Pain management procedures appear on the OIG’s Annual Work Plan as areas of compliance focus — including epidural steroid injections, facet procedures, and neurostimulation. The OIG monitors for billing patterns that suggest services were billed without meeting coverage criteria, at frequencies exceeding payer limits, or with documentation that doesn’t support the codes billed. The best compliance posture is proactive: correct documentation before claim submission, frequency tracking per patient per level, and authorization management that prevents billing of unauthorized procedures.


Practice Operations Questions

Q: Should a pain management practice outsource billing or manage it in-house?

The deciding factor is specialty-specific expertise. Pain management billing — interventional procedure coding, approach-specific ESI codes, RFA authorization with MBB documentation packages, imaging guidance compliance, multiple procedure reduction reconciliation — requires billing knowledge that generalist in-house billing teams and generalist billing companies rarely maintain at adequate depth. Practices with high denial rates, imaging guidance billing gaps, or authorization failures are almost always benefiting from switching to a specialized billing partner. A billing audit quantifies whether the revenue gap justifies the change.

Q: How do I know if my pain management billing company is actually specialized?

Ask specific questions. Ask them to explain the documentation requirements to bill CPT 77003. Ask how they handle RFA prior authorization. Ask how they verify multiple procedure reductions against your contracted rates. Ask about HCPCS C1607 for SCS implants. If the answers are specific and immediate, the company has genuine pain management expertise. If the answers are vague or require a lookup, they are a generalist billing company with pain management listed as a specialty.

Q: What is a clean claim rate and what should it be for pain management?

The clean claim rate is the percentage of claims accepted and paid on first submission without requiring correction or resubmission. Industry benchmark for well-managed outpatient practices is 95% or higher. Most pain management practices without specialty-specific billing expertise operate at 78–87%. The gap between 85% and 95% clean claim rates in a practice billing 650 claims per month at $380 average allowable represents approximately $24,700 per month in claims that are delayed 30–45 additional days due to rework — plus the administrative cost of that rework.

Q: How long should AR follow-up take for a denied RFA claim?

A denied RFA claim should receive active follow-up within 15 days of the denial date. The first action is root cause classification — why was the claim denied? If medical necessity, is a peer-to-peer review appropriate? If authorization, is retro-authorization available? If documentation, what records are needed for appeal? A formal appeal should be filed within 30 days of denial. Most commercial payer appeal windows are 60–180 days from denial date. Allowing an RFA denial to sit unworked for 60+ days risks approaching the appeal window without action on a claim worth $1,500–$3,000 or more.


Questions About Malakos Healthcare Solutions

Q: What pain management billing services does Malakos Healthcare Solutions provide?

Malakos Healthcare Solutions provides complete pain management billing and revenue cycle management services including: eligibility verification with procedure-specific coverage confirmation, prior authorization management for all interventional pain procedure categories (ESI, facet, RFA, SCS, nerve blocks), approach-specific CPT coding with procedure note review, imaging guidance documentation verification, payment posting with contracted rate reconciliation, denial management with peer-to-peer coordination, value-weighted AR follow-up on a 15/30/60-day cycle, and credentialing maintenance. Services are delivered through your existing EHR and practice management system — no migration required.

Q: How does Malakos handle RFA prior authorization?

Malakos assembles the complete RFA authorization package before submission — both prior MBB procedure notes with documented pain relief percentages, duration of relief, payer-specific threshold verification (50% vs. 80% by payer), functional impairment documentation, and provider attestation. When RFA authorization is denied on first submission, Malakos coordinates peer-to-peer review between the treating physician and the payer’s medical director. First-pass RFA authorization approval rates with Malakos exceed 80%.

Q: Does Malakos offer a free billing audit for pain management practices?

Yes. Every engagement with Malakos Healthcare Solutions begins with a free billing audit covering current claims data, denial patterns by procedure type and payer, AR aging, imaging guidance capture rate, multiple procedure reduction reconciliation, authorization gap history, and E/M coding distribution. Results are presented in specific dollar terms — not industry benchmarks. No commitment required.

Q: Where is Malakos Healthcare Solutions located?

Malakos Healthcare Solutions is headquartered in Cheyenne, Wyoming — the only specialty-specific medical billing company based in Wyoming. Malakos serves pain management practices across Wyoming and nationwide, operating remotely through clients’ existing EHR systems with no geographic limitation.


How Malakos Healthcare Solutions Can Help

Every question in this guide represents a real revenue or compliance risk in pain management billing. The practices that get the answers right — and build billing workflows around them — collect more of what they earn, avoid more denials, and carry less compliance exposure.

Malakos Healthcare Solutions provides the pain management billing expertise to get these answers right on every claim, every authorization, and every payment posting — for independent interventional pain practices across the United States.

Schedule a free billing audit to find out exactly where your practice’s billing stands on each of these questions — in specific dollar terms.

Schedule Your Free Pain Management Billing Audit

📞 +1 (307) 441-3431 ✉️ support@malakoshcs.com 🌐 malakoshealthcaresolutions.com 📍 Cheyenne, Wyoming


Related Reading


Malakos Healthcare Solutions | Pain Management Billing Services USA | This guide reflects 2026 AMA CPT guidelines, CMS Physician Fee Schedule rates, and current payer standards. Individual payer policies vary. Serving interventional pain practices nationwide since 2022.